NASDAQ: ABMD (ABIOMED Inc.) director Dorothy E. Phuy sold 7500 ABMD shares of stock on 15th July 2020. It is estimated that the sold-out stocks hold an average $275 price. The estimated total value is $2.06 Million. As a result, Dorothy now owns 7650 direct company shares. Plus, ABMD shares traded up high by $11.51 last Friday. Because of that, many traders are now interested in investing in ABMD!
NASDAQ: ABMD at https://www.webull.com/quote/nasdaq-abmd works in the field of medical research and development. ABMD mainly sells medical equipment for cardiac patients. The company also offers Impella 2.5 catheter which is a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology. This company sells its product directly and through clinical support personnel in the United States.
ABMD current stock Price and last quarter earnings report:
ABMD’s stock was trading at $151.13 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then its stock value increased by 88.3% and is trading now at $284.55(as of 19th July 2020).
Price to earnings ratio is the ratio of the company’s stock price to the company’s earnings per share and is used to compare the valuation of a company with peers in the industry. Its Forward P/E ratio is 88.64 and the trailing P/E ratio is 64.38. This organization earned $206.66million during the quarter, compared to the consensus estimate of $209.58 million. NASDAQ: ABMD reported earnings per share (EPS) for the quarter is $0.70beating the Zacks’ consensus estimate of ($0.96 by $0.26). The next earning date is scheduled to release on Thursday, 6th August of 2020.
Company profitability and price target:
Profit margin is a useful ratio and can help provide an insight into a variety of aspects of financial performance. The profit margin may also indicate certain things about the company’s ability to manage its expenses. The company has a market capitalization of $12.82 billion and generates $840.88 million in revenue each year. As of the most recent Fiscal, the Year company’s earnings per share is $4.74 and Net income (Profit) is $203.01million. Research analysts have issued 1-year price targets which range from $152.00 to $240.00. On average, they expect the share price to reach $193.00 in the next year which suggests a possible downside of 32.2%.
Is it the right time to invest in ABMD?
News related to ABMDstock has been trending somewhat positive on Saturday, according to the Info Trie Sentiment. The researchers identify negative and positive media coverage by reviewing more than six thousand news and blog sources. NASDAQ: ABMD got coverage by the media recently indicating it will affect the company’s share price in the next several days. You can check more stock news at free trading app. Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.